ORIQW peer analysis
ORIQW (ORIQW) against its competitors: price, today's move, 1-year return and market value side by side.
- ORIQW's peers: BENF (Beneficient), CHARR (Charlton Aria Acquisition), CLDI (Calidi Biotherapeutics), MKLYR (McKinley Acquisition Corporation Rights), PGAC (Pantages Capital Acquisition), RMCO (Royalty Management), SSEAR (Starry Sea Acquisition Corp Rights).
ORIQW and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BENF Beneficient | $0.48 | -8.69% | -89.48% | $7.37M |
| CHARR Charlton Aria Acquisition | $0.15 | -15.95% | – | $1.62M |
| CLDI Calidi Biotherapeutics | $0.51 | -4.23% | -97.88% | $1.74M |
| MKLYR McKinley Acquisition Corporation Rights | $0.21 | -0.05% | – | $3.70M |
| PGAC Pantages Capital Acquisition | $10.87 | -0.09% | – | $55.83M |
| RMCO Royalty Management | $2.06 | -5.07% | -33.23% | $31.29M |
| SSEAR Starry Sea Acquisition Corp Rights | $0.07 | 0.00% | – | $80.41M |
| ORIQW Origin Investment Corp I Warrant. | $0.14 | 0.00% | – | $1.31M |